nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—Pulmonary eosinophilia—Dapsone—leprosy	0.0693	0.0875	CcSEcCtD
Fosinopril—ACE—hindlimb—leprosy	0.0382	0.184	CbGeAlD
Fosinopril—ACE—arm—leprosy	0.0365	0.175	CbGeAlD
Fosinopril—ACE—appendage—leprosy	0.0328	0.157	CbGeAlD
Fosinopril—ACE—peripheral nervous system—leprosy	0.0298	0.143	CbGeAlD
Fosinopril—Anaemia megaloblastic—Thalidomide—leprosy	0.0275	0.0347	CcSEcCtD
Fosinopril—ACE—nerve—leprosy	0.0232	0.112	CbGeAlD
Fosinopril—ACE—blood vessel—leprosy	0.0183	0.0876	CbGeAlD
Fosinopril—Proteinuria—Dapsone—leprosy	0.0144	0.0182	CcSEcCtD
Fosinopril—Protein urine present—Dapsone—leprosy	0.0142	0.0179	CcSEcCtD
Fosinopril—Peripheral vascular disorder—Thalidomide—leprosy	0.0132	0.0167	CcSEcCtD
Fosinopril—Transient ischaemic attack—Thalidomide—leprosy	0.0128	0.0162	CcSEcCtD
Fosinopril—Sexual dysfunction—Thalidomide—leprosy	0.0116	0.0146	CcSEcCtD
Fosinopril—Serum creatinine increased—Thalidomide—leprosy	0.0105	0.0133	CcSEcCtD
Fosinopril—Nail disorder—Thalidomide—leprosy	0.00998	0.0126	CcSEcCtD
Fosinopril—ACE—eye—leprosy	0.00971	0.0466	CbGeAlD
Fosinopril—Menstrual disorder—Thalidomide—leprosy	0.0095	0.012	CcSEcCtD
Fosinopril—Intestinal obstruction—Thalidomide—leprosy	0.0095	0.012	CcSEcCtD
Fosinopril—Hepatomegaly—Thalidomide—leprosy	0.00915	0.0116	CcSEcCtD
Fosinopril—Muscular weakness—Dapsone—leprosy	0.0081	0.0102	CcSEcCtD
Fosinopril—Influenza—Dapsone—leprosy	0.00794	0.01	CcSEcCtD
Fosinopril—Numbness—Thalidomide—leprosy	0.00781	0.00987	CcSEcCtD
Fosinopril—Pancreatitis—Dapsone—leprosy	0.00778	0.00983	CcSEcCtD
Fosinopril—Sensory loss—Thalidomide—leprosy	0.00748	0.00944	CcSEcCtD
Fosinopril—Proteinuria—Thalidomide—leprosy	0.00737	0.00931	CcSEcCtD
Fosinopril—Protein urine present—Thalidomide—leprosy	0.00727	0.00918	CcSEcCtD
Fosinopril—Photosensitivity reaction—Dapsone—leprosy	0.00724	0.00915	CcSEcCtD
Fosinopril—Viral infection—Thalidomide—leprosy	0.00717	0.00906	CcSEcCtD
Fosinopril—Oliguria—Thalidomide—leprosy	0.00703	0.00888	CcSEcCtD
Fosinopril—Drug interaction—Thalidomide—leprosy	0.00698	0.00882	CcSEcCtD
Fosinopril—Neuropathy peripheral—Dapsone—leprosy	0.00694	0.00876	CcSEcCtD
Fosinopril—Leukocytosis—Thalidomide—leprosy	0.00689	0.0087	CcSEcCtD
Fosinopril—Creatinine increased—Thalidomide—leprosy	0.0068	0.00859	CcSEcCtD
Fosinopril—Sinusitis—Dapsone—leprosy	0.00664	0.00839	CcSEcCtD
Fosinopril—Eructation—Thalidomide—leprosy	0.00636	0.00804	CcSEcCtD
Fosinopril—Hyperkalaemia—Thalidomide—leprosy	0.00636	0.00804	CcSEcCtD
Fosinopril—Pharyngitis—Dapsone—leprosy	0.00631	0.00796	CcSEcCtD
Fosinopril—Aplastic anaemia—Thalidomide—leprosy	0.00608	0.00768	CcSEcCtD
Fosinopril—Neuropathy—Thalidomide—leprosy	0.00608	0.00768	CcSEcCtD
Fosinopril—Tinnitus—Dapsone—leprosy	0.00592	0.00748	CcSEcCtD
Fosinopril—Lightheadedness—Thalidomide—leprosy	0.00579	0.00732	CcSEcCtD
Fosinopril—Pulmonary oedema—Thalidomide—leprosy	0.00576	0.00728	CcSEcCtD
Fosinopril—Lymphadenopathy—Thalidomide—leprosy	0.00551	0.00696	CcSEcCtD
Fosinopril—Diabetes mellitus—Thalidomide—leprosy	0.0054	0.00683	CcSEcCtD
Fosinopril—Photosensitivity—Thalidomide—leprosy	0.00535	0.00676	CcSEcCtD
Fosinopril—ACE—testis—leprosy	0.00533	0.0256	CbGeAlD
Fosinopril—Gastroenteritis—Thalidomide—leprosy	0.0053	0.0067	CcSEcCtD
Fosinopril—Vascular purpura—Thalidomide—leprosy	0.00526	0.00664	CcSEcCtD
Fosinopril—ACE—nervous system—leprosy	0.00523	0.0251	CbGeAlD
Fosinopril—Vision blurred—Dapsone—leprosy	0.00521	0.00658	CcSEcCtD
Fosinopril—Injury—Thalidomide—leprosy	0.00511	0.00646	CcSEcCtD
Fosinopril—Renal failure acute—Thalidomide—leprosy	0.00509	0.00643	CcSEcCtD
Fosinopril—Libido decreased—Thalidomide—leprosy	0.00507	0.0064	CcSEcCtD
Fosinopril—Increased appetite—Thalidomide—leprosy	0.005	0.00632	CcSEcCtD
Fosinopril—Dermatitis exfoliative—Thalidomide—leprosy	0.00498	0.00629	CcSEcCtD
Fosinopril—Vertigo—Dapsone—leprosy	0.00497	0.00628	CcSEcCtD
Fosinopril—Dermatitis bullous—Thalidomide—leprosy	0.00492	0.00621	CcSEcCtD
Fosinopril—Purpura—Thalidomide—leprosy	0.00488	0.00616	CcSEcCtD
Fosinopril—Arthritis—Thalidomide—leprosy	0.00484	0.00611	CcSEcCtD
Fosinopril—Cough—Dapsone—leprosy	0.00483	0.0061	CcSEcCtD
Fosinopril—Cerebrovascular accident—Thalidomide—leprosy	0.0048	0.00606	CcSEcCtD
Fosinopril—Hyponatraemia—Thalidomide—leprosy	0.00472	0.00596	CcSEcCtD
Fosinopril—Disturbance in sexual arousal—Thalidomide—leprosy	0.00466	0.00589	CcSEcCtD
Fosinopril—SLC15A2—testis—leprosy	0.00464	0.0223	CbGeAlD
Fosinopril—Affect lability—Thalidomide—leprosy	0.00463	0.00584	CcSEcCtD
Fosinopril—SLC15A2—nervous system—leprosy	0.00456	0.0219	CbGeAlD
Fosinopril—Cardiac arrest—Thalidomide—leprosy	0.00447	0.00565	CcSEcCtD
Fosinopril—Mood swings—Thalidomide—leprosy	0.00445	0.00562	CcSEcCtD
Fosinopril—Tachycardia—Dapsone—leprosy	0.00441	0.00556	CcSEcCtD
Fosinopril—Blood creatinine increased—Thalidomide—leprosy	0.0044	0.00556	CcSEcCtD
Fosinopril—Dry skin—Thalidomide—leprosy	0.00431	0.00544	CcSEcCtD
Fosinopril—Orthostatic hypotension—Thalidomide—leprosy	0.00429	0.00542	CcSEcCtD
Fosinopril—Breast disorder—Thalidomide—leprosy	0.00425	0.00537	CcSEcCtD
Fosinopril—Cramp muscle—Thalidomide—leprosy	0.00423	0.00535	CcSEcCtD
Fosinopril—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00423	0.00535	CcSEcCtD
Fosinopril—Muscular weakness—Thalidomide—leprosy	0.00415	0.00524	CcSEcCtD
Fosinopril—Abdominal distension—Thalidomide—leprosy	0.00409	0.00517	CcSEcCtD
Fosinopril—Insomnia—Dapsone—leprosy	0.00408	0.00516	CcSEcCtD
Fosinopril—Influenza—Thalidomide—leprosy	0.00406	0.00513	CcSEcCtD
Fosinopril—Dysphagia—Thalidomide—leprosy	0.00406	0.00513	CcSEcCtD
Fosinopril—Eosinophilia—Thalidomide—leprosy	0.00402	0.00508	CcSEcCtD
Fosinopril—Bronchospasm—Thalidomide—leprosy	0.004	0.00505	CcSEcCtD
Fosinopril—Pancreatitis—Thalidomide—leprosy	0.00398	0.00503	CcSEcCtD
Fosinopril—Angina pectoris—Thalidomide—leprosy	0.00396	0.005	CcSEcCtD
Fosinopril—Pancytopenia—Thalidomide—leprosy	0.00386	0.00487	CcSEcCtD
Fosinopril—Neutropenia—Thalidomide—leprosy	0.0038	0.0048	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Thalidomide—leprosy	0.00378	0.00477	CcSEcCtD
Fosinopril—Pollakiuria—Thalidomide—leprosy	0.00375	0.00474	CcSEcCtD
Fosinopril—Erectile dysfunction—Thalidomide—leprosy	0.00374	0.00473	CcSEcCtD
Fosinopril—Photosensitivity reaction—Thalidomide—leprosy	0.00371	0.00468	CcSEcCtD
Fosinopril—Weight increased—Thalidomide—leprosy	0.0037	0.00467	CcSEcCtD
Fosinopril—Gastrointestinal pain—Dapsone—leprosy	0.00369	0.00466	CcSEcCtD
Fosinopril—Weight decreased—Thalidomide—leprosy	0.00368	0.00464	CcSEcCtD
Fosinopril—Pneumonia—Thalidomide—leprosy	0.00364	0.0046	CcSEcCtD
Fosinopril—Drowsiness—Thalidomide—leprosy	0.00362	0.00458	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00359	0.00454	CcSEcCtD
Fosinopril—Acute coronary syndrome—Thalidomide—leprosy	0.00357	0.00451	CcSEcCtD
Fosinopril—Body temperature increased—Dapsone—leprosy	0.00357	0.00451	CcSEcCtD
Fosinopril—Abdominal pain—Dapsone—leprosy	0.00357	0.00451	CcSEcCtD
Fosinopril—Renal failure—Thalidomide—leprosy	0.00356	0.0045	CcSEcCtD
Fosinopril—Neuropathy peripheral—Thalidomide—leprosy	0.00355	0.00449	CcSEcCtD
Fosinopril—Myocardial infarction—Thalidomide—leprosy	0.00355	0.00449	CcSEcCtD
Fosinopril—Epistaxis—Thalidomide—leprosy	0.00342	0.00432	CcSEcCtD
Fosinopril—Sinusitis—Thalidomide—leprosy	0.0034	0.00429	CcSEcCtD
Fosinopril—Agranulocytosis—Thalidomide—leprosy	0.00338	0.00427	CcSEcCtD
Fosinopril—Bradycardia—Thalidomide—leprosy	0.00331	0.00418	CcSEcCtD
Fosinopril—Rhinitis—Thalidomide—leprosy	0.00326	0.00412	CcSEcCtD
Fosinopril—Hepatitis—Thalidomide—leprosy	0.00325	0.00411	CcSEcCtD
Fosinopril—Hypoaesthesia—Thalidomide—leprosy	0.00324	0.00409	CcSEcCtD
Fosinopril—Pharyngitis—Thalidomide—leprosy	0.00323	0.00408	CcSEcCtD
Fosinopril—Oedema peripheral—Thalidomide—leprosy	0.0032	0.00405	CcSEcCtD
Fosinopril—Visual impairment—Thalidomide—leprosy	0.00313	0.00396	CcSEcCtD
Fosinopril—Erythema multiforme—Thalidomide—leprosy	0.00307	0.00388	CcSEcCtD
Fosinopril—Tinnitus—Thalidomide—leprosy	0.00303	0.00383	CcSEcCtD
Fosinopril—Chills—Thalidomide—leprosy	0.00292	0.00369	CcSEcCtD
Fosinopril—Arrhythmia—Thalidomide—leprosy	0.00291	0.00367	CcSEcCtD
Fosinopril—Vomiting—Dapsone—leprosy	0.00287	0.00362	CcSEcCtD
Fosinopril—Headache—Dapsone—leprosy	0.00283	0.00357	CcSEcCtD
Fosinopril—Flatulence—Thalidomide—leprosy	0.00279	0.00352	CcSEcCtD
Fosinopril—Tension—Thalidomide—leprosy	0.00278	0.00351	CcSEcCtD
Fosinopril—Dysgeusia—Thalidomide—leprosy	0.00277	0.0035	CcSEcCtD
Fosinopril—Nervousness—Thalidomide—leprosy	0.00275	0.00347	CcSEcCtD
Fosinopril—Muscle spasms—Thalidomide—leprosy	0.00272	0.00344	CcSEcCtD
Fosinopril—Nausea—Dapsone—leprosy	0.00268	0.00339	CcSEcCtD
Fosinopril—Vision blurred—Thalidomide—leprosy	0.00267	0.00337	CcSEcCtD
Fosinopril—Tremor—Thalidomide—leprosy	0.00265	0.00335	CcSEcCtD
Fosinopril—Ill-defined disorder—Thalidomide—leprosy	0.00263	0.00332	CcSEcCtD
Fosinopril—Anaemia—Thalidomide—leprosy	0.00262	0.0033	CcSEcCtD
Fosinopril—Agitation—Thalidomide—leprosy	0.0026	0.00329	CcSEcCtD
Fosinopril—Angioedema—Thalidomide—leprosy	0.00259	0.00327	CcSEcCtD
Fosinopril—Malaise—Thalidomide—leprosy	0.00255	0.00322	CcSEcCtD
Fosinopril—Vertigo—Thalidomide—leprosy	0.00254	0.00321	CcSEcCtD
Fosinopril—Syncope—Thalidomide—leprosy	0.00254	0.00321	CcSEcCtD
Fosinopril—Leukopenia—Thalidomide—leprosy	0.00253	0.0032	CcSEcCtD
Fosinopril—Palpitations—Thalidomide—leprosy	0.0025	0.00316	CcSEcCtD
Fosinopril—Loss of consciousness—Thalidomide—leprosy	0.00249	0.00314	CcSEcCtD
Fosinopril—Cough—Thalidomide—leprosy	0.00247	0.00312	CcSEcCtD
Fosinopril—Hypertension—Thalidomide—leprosy	0.00244	0.00309	CcSEcCtD
Fosinopril—Arthralgia—Thalidomide—leprosy	0.00241	0.00304	CcSEcCtD
Fosinopril—Myalgia—Thalidomide—leprosy	0.00241	0.00304	CcSEcCtD
Fosinopril—Chest pain—Thalidomide—leprosy	0.00241	0.00304	CcSEcCtD
Fosinopril—Discomfort—Thalidomide—leprosy	0.00238	0.00301	CcSEcCtD
Fosinopril—Dry mouth—Thalidomide—leprosy	0.00236	0.00298	CcSEcCtD
Fosinopril—Confusional state—Thalidomide—leprosy	0.00233	0.00294	CcSEcCtD
Fosinopril—Oedema—Thalidomide—leprosy	0.00231	0.00292	CcSEcCtD
Fosinopril—Infection—Thalidomide—leprosy	0.0023	0.0029	CcSEcCtD
Fosinopril—Shock—Thalidomide—leprosy	0.00227	0.00287	CcSEcCtD
Fosinopril—Thrombocytopenia—Thalidomide—leprosy	0.00226	0.00286	CcSEcCtD
Fosinopril—Tachycardia—Thalidomide—leprosy	0.00226	0.00285	CcSEcCtD
Fosinopril—Hyperhidrosis—Thalidomide—leprosy	0.00223	0.00282	CcSEcCtD
Fosinopril—Anorexia—Thalidomide—leprosy	0.0022	0.00278	CcSEcCtD
Fosinopril—Hypotension—Thalidomide—leprosy	0.00216	0.00273	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Thalidomide—leprosy	0.00211	0.00266	CcSEcCtD
Fosinopril—Insomnia—Thalidomide—leprosy	0.00209	0.00264	CcSEcCtD
Fosinopril—Paraesthesia—Thalidomide—leprosy	0.00207	0.00262	CcSEcCtD
Fosinopril—Dyspnoea—Thalidomide—leprosy	0.00206	0.0026	CcSEcCtD
Fosinopril—Somnolence—Thalidomide—leprosy	0.00205	0.00259	CcSEcCtD
Fosinopril—Dyspepsia—Thalidomide—leprosy	0.00203	0.00257	CcSEcCtD
Fosinopril—Decreased appetite—Thalidomide—leprosy	0.00201	0.00254	CcSEcCtD
Fosinopril—Fatigue—Thalidomide—leprosy	0.00199	0.00252	CcSEcCtD
Fosinopril—Constipation—Thalidomide—leprosy	0.00198	0.0025	CcSEcCtD
Fosinopril—Pain—Thalidomide—leprosy	0.00198	0.0025	CcSEcCtD
Fosinopril—Feeling abnormal—Thalidomide—leprosy	0.0019	0.0024	CcSEcCtD
Fosinopril—Gastrointestinal pain—Thalidomide—leprosy	0.00189	0.00239	CcSEcCtD
Fosinopril—Urticaria—Thalidomide—leprosy	0.00184	0.00232	CcSEcCtD
Fosinopril—Abdominal pain—Thalidomide—leprosy	0.00183	0.00231	CcSEcCtD
Fosinopril—Body temperature increased—Thalidomide—leprosy	0.00183	0.00231	CcSEcCtD
Fosinopril—Hypersensitivity—Thalidomide—leprosy	0.0017	0.00215	CcSEcCtD
Fosinopril—Asthenia—Thalidomide—leprosy	0.00166	0.00209	CcSEcCtD
Fosinopril—Pruritus—Thalidomide—leprosy	0.00163	0.00206	CcSEcCtD
Fosinopril—Diarrhoea—Thalidomide—leprosy	0.00158	0.002	CcSEcCtD
Fosinopril—Dizziness—Thalidomide—leprosy	0.00153	0.00193	CcSEcCtD
Fosinopril—Vomiting—Thalidomide—leprosy	0.00147	0.00186	CcSEcCtD
Fosinopril—Rash—Thalidomide—leprosy	0.00146	0.00184	CcSEcCtD
Fosinopril—Dermatitis—Thalidomide—leprosy	0.00146	0.00184	CcSEcCtD
Fosinopril—Headache—Thalidomide—leprosy	0.00145	0.00183	CcSEcCtD
Fosinopril—Nausea—Thalidomide—leprosy	0.00137	0.00173	CcSEcCtD
